Dr Carraway on the Importance of NGS in Relapsed/Refractory AML

Hetty E. Carraway, MD, MBA, discusses the importance of testing for targetable mutations in patients with relapsed/refractory acute myeloid leukemia.

Related Keywords

,Division Of Hematologic Oncology ,Oncology Program ,Enterprise Development ,Department Of Medicine ,Case Comprehensive Cancer Center ,Taussig Cancer Institute ,School Of Medicine ,Cleveland Clinic Lerner College ,Case Western Reserve University ,Immune Oncology Program ,Hematologic Oncology ,Blood Disorders ,Cleveland Clinic ,